Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nova Max Creatinine and eGFR Meter System - Evaluation

NCT05118074 is registered in ClinicalTrials.gov with Nova Biomedical as lead sponsor.

NCT NCT05118074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05118074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nova Max Creatinine and eGFR Meter System - Evaluation
Lead sponsor
Nova Biomedical
Phase
Observational
Overall status
Completed
Start date
June 8, 2021
Completion date
April 15, 2024
Enrollment
360 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, chronic kidney diseases